X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (41525) 41525
Newsletter (1724) 1724
Newspaper Article (240) 240
Magazine Article (174) 174
Book Chapter (60) 60
Transcript (51) 51
Government Document (38) 38
Book / eBook (35) 35
Patent (32) 32
Dissertation (17) 17
Conference Proceeding (10) 10
Publication (4) 4
Book Review (2) 2
Reference (2) 2
Report (2) 2
Web Resource (2) 2
Journal / eJournal (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (38250) 38250
female (24034) 24034
male (23803) 23803
adult (18121) 18121
middle aged (16608) 16608
cross-sectional studies (15996) 15996
aged (10389) 10389
infectious diseases (10002) 10002
risk factors (8114) 8114
adolescent (7694) 7694
nosocomial infections (7645) 7645
cross infection (7556) 7556
health aspects (6763) 6763
cross infection - drug therapy (6724) 6724
young adult (6367) 6367
anti-bacterial agents - therapeutic use (6206) 6206
prevalence (6182) 6182
cross infection - microbiology (5928) 5928
research (5555) 5555
microbiology (4869) 4869
child (4695) 4695
hiv (4664) 4664
infections (4574) 4574
analysis (4570) 4570
cross infection - epidemiology (4488) 4488
epidemiology (4364) 4364
aged, 80 and over (4190) 4190
immunology (3976) 3976
care and treatment (3968) 3968
infection (3806) 3806
hiv infections - drug therapy (3798) 3798
treatment outcome (3733) 3733
mortality (3724) 3724
retrospective studies (3670) 3670
pharmacology & pharmacy (3511) 3511
public, environmental & occupational health (3432) 3432
child, preschool (3384) 3384
research article (3384) 3384
antibiotics (3354) 3354
microbial sensitivity tests (3276) 3276
hospitals (3273) 3273
cross-over studies (3191) 3191
animals (3127) 3127
prospective studies (3081) 3081
medical research (3057) 3057
cross infection - prevention & control (3042) 3042
drug therapy (3027) 3027
surveys and questionnaires (2940) 2940
human immunodeficiency virus--hiv (2923) 2923
medicine (2886) 2886
infant (2792) 2792
diagnosis (2728) 2728
anti-bacterial agents - pharmacology (2680) 2680
prevention (2643) 2643
risk-factors (2604) 2604
therapy (2589) 2589
medicine, experimental (2561) 2561
drug resistance (2560) 2560
children (2539) 2539
medicine & public health (2446) 2446
medicine, general & internal (2435) 2435
drug resistance in microorganisms (2325) 2325
patients (2301) 2301
studies (2275) 2275
pneumonia (2230) 2230
risk (2205) 2205
disease (2126) 2126
public health (2094) 2094
infant, newborn (2081) 2081
incidence (2066) 2066
hiv infections - epidemiology (2033) 2033
antiretroviral therapy (1988) 1988
pediatrics (1976) 1976
management (1960) 1960
internal medicine (1938) 1938
aids (1928) 1928
hiv infection (1912) 1912
intensive care units (1881) 1881
time factors (1866) 1866
usage (1842) 1842
multidisciplinary sciences (1719) 1719
staphylococcus aureus (1682) 1682
drug resistance, microbial (1666) 1666
surgery (1630) 1630
infectious disease (1620) 1620
drug resistance, bacterial (1614) 1614
staphylococcal infections - drug therapy (1612) 1612
hiv infections - complications (1600) 1600
bacteria (1584) 1584
cohort studies (1566) 1566
acquired immune deficiency syndrome--aids (1544) 1544
drugs (1523) 1523
anti-hiv agents - therapeutic use (1521) 1521
impact (1494) 1494
infection control (1486) 1486
science (1478) 1478
double-blind method (1461) 1461
logistic models (1453) 1453
case-control studies (1443) 1443
anti-bacterial agents - administration & dosage (1425) 1425
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (15) 15
Online Resources - Online (4) 4
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Scarborough Hospital - General (2) 2
Baycrest Hospital - Stacks (1) 1
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Circulation Desk (1) 1
Lakeridge Health Sciences - Online (1) 1
New College (Ivey) - Stacks (1) 1
OISE - Stacks (1) 1
Providence Healthcare - Stacks (1) 1
Scarborough Hospital - Online (1) 1
St. Michael's Hospital - Online (1) 1
St. Michael's Hospital - Stacks (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
Thomas Fisher Rare Book - Rare Book (1) 1
University College (Laidlaw) - Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
UofT at Scarborough - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (41434) 41434
German (611) 611
Spanish (546) 546
French (523) 523
Russian (198) 198
Japanese (170) 170
Italian (127) 127
Chinese (104) 104
Portuguese (104) 104
Polish (82) 82
Turkish (46) 46
Romanian (45) 45
Dutch (41) 41
Czech (24) 24
Danish (24) 24
Swedish (21) 21
Norwegian (16) 16
Hungarian (15) 15
Serbian (12) 12
Croatian (9) 9
Finnish (6) 6
Lithuanian (6) 6
Hebrew (5) 5
Ukrainian (4) 4
Arabic (3) 3
Bulgarian (3) 3
Korean (3) 3
Icelandic (2) 2
Slovak (2) 2
Afrikaans (1) 1
Bosnian (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Expert review of anti-infective therapy, ISSN 1478-7210, 2003
Journal
Journal Article
Journal of Preventive Medicine and Hygiene, ISSN 1121-2233, 2017, Volume 58, Issue 4, pp. E294 - E301
National efforts to curtail healthcare-associated infections (HAI) proliferated recently, though data detailing progress over time are limited... 
Bloodstream infections | Urinary tract infections | Antimicrobial resistance | Multidrug-resistant organisms | Surgical site infections | Humans | Middle Aged | Drug Resistance, Bacterial | Male | Incidence | Gram-Negative Bacterial Infections - microbiology | Young Adult | Gram-Positive Bacterial Infections - microbiology | Urinary Tract Infections - microbiology | Odds Ratio | Staphylococcus aureus | Enterococcus | Bacteremia - drug therapy | Gram-Negative Bacterial Infections - drug therapy | Logistic Models | Pseudomonas Infections - microbiology | Gram-Positive Bacterial Infections - epidemiology | Streptococcus pneumoniae | Acinetobacter baumannii | Cross Infection - microbiology | Adolescent | Gram-Negative Bacterial Infections - epidemiology | Bacteremia - epidemiology | New York City - epidemiology | Surgical Wound Infection - microbiology | Gram-Positive Bacterial Infections - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Klebsiella Infections - epidemiology | Surgical Wound Infection - drug therapy | Adult | Female | Pseudomonas aeruginosa | Retrospective Studies | Staphylococcal Infections - microbiology | Acinetobacter Infections - microbiology | Cross Infection - epidemiology | Streptococcal Infections - microbiology | Staphylococcal Infections - drug therapy | Surgical Wound Infection - epidemiology | Klebsiella Infections - drug therapy | Pneumonia - epidemiology | Pseudomonas Infections - drug therapy | Acinetobacter Infections - drug therapy | Streptococcal Infections - epidemiology | Pneumonia - microbiology | Klebsiella Infections - microbiology | Urinary Tract Infections - drug therapy | Urinary Tract Infections - epidemiology | Pneumonia - drug therapy | Staphylococcal Infections - epidemiology | Pseudomonas Infections - epidemiology | Acinetobacter Infections - epidemiology | Streptococcal Infections - drug therapy | Aged | Klebsiella pneumoniae
Journal Article
The Lancet infectious diseases, ISSN 1473-3099, 2014, Volume 14, Issue 11, pp. 1136 - 1149
.... New viral respiratory tract infections with epidemic potential, such as severe acute respiratory syndrome, swine-origin influenza A H1N1, and Middle East respiratory syndrome coronavirus infection... 
Infectious Disease | INFECTIOUS DISEASES | INFLUENZA-A | ASPERGILLUS-FUMIGATUS | IN-VITRO | VIRUS-INFECTION | A DOUBLE-BLIND | OPEN-LABEL | CRITICALLY-ILL PATIENTS | T-CELLS | SYNDROME CORONAVIRUS | H1N1 VIRUS | Mycoses - epidemiology | Virus Diseases - epidemiology | Biological Therapy - methods | Biological Therapy - trends | Humans | Drug Resistance, Viral | Drug Resistance, Bacterial | Mycoses - microbiology | Virus Diseases - virology | Antifungal Agents - therapeutic use | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Virus Diseases - drug therapy | Respiratory Tract Infections - virology | Drug Resistance, Fungal | Bacterial Infections - microbiology | Drug Therapy - trends | Antifungal Agents - pharmacology | Antiviral Agents - pharmacology | Antiviral Agents - therapeutic use | Bacterial Infections - drug therapy | Drug Discovery - trends | Respiratory Tract Infections - drug therapy | Treatment Outcome | Drug Therapy - methods | Bacterial Infections - epidemiology | Mycoses - drug therapy | Anti-Bacterial Agents - pharmacology | Respiratory Tract Infections - epidemiology | Antiviral agents | Hospitals | Influenza | Mycoses | Development and progression | Bacteria | Cross infection | Nosocomial infections | Drug therapy | Cells | Drug resistance in microorganisms | Severe acute respiratory syndrome | Respiratory agents | Pandemics | Mortality | Respiratory diseases | Viral infections
Journal Article
Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 4, pp. 387 - 396
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2016, Volume 11, Issue 12, p. e0167522
In this study, we retrospectively reviewed the clinical experience of patients receiving doripenem-containing regimens for the treatment of healthcare-associated infections (HCAIs... 
IN-VITRO | MULTICENTER | BACTERIAL-INFECTIONS | IMIPENEM-CILASTATIN | EFFICACY | VENTILATOR-ASSOCIATED PNEUMONIA | SAFETY | PSEUDOMONAS-AERUGINOSA | MULTIDISCIPLINARY SCIENCES | SURVEILLANCE | ANTIMICROBIAL ACTIVITY | Soft Tissue Infections - mortality | Urinary Tract Infections - mortality | Humans | Middle Aged | Cross Infection - mortality | Male | Tertiary Care Centers - statistics & numerical data | Hospital Mortality - trends | Respiratory Tract Infections - microbiology | Anti-Bacterial Agents - therapeutic use | Cross Infection - pathology | Respiratory Tract Infections - mortality | Soft Tissue Infections - pathology | Aged, 80 and over | Female | Urinary Tract Infections - microbiology | Urinary Tract Infections - pathology | Retrospective Studies | Soft Tissue Infections - drug therapy | Respiratory Tract Infections - pathology | Intraabdominal Infections - microbiology | Respiratory Tract Infections - drug therapy | Treatment Outcome | Cross Infection - drug therapy | Urinary Tract Infections - drug therapy | Intraabdominal Infections - mortality | Intraabdominal Infections - pathology | Soft Tissue Infections - microbiology | Carbapenems - therapeutic use | Cross Infection - microbiology | Aged | Intraabdominal Infections - drug therapy | APACHE | Infection | Doripenem | Care and treatment | Dosage and administration | Health care | Therapy | Pneumonia | Intensive care | Health services | Medical records | Infections | Urinary tract | Drug resistance | Respiratory tract | Respiratory tract diseases | Urinary tract infections | Urogenital system | Pathogens | Ventilators | Medical research | Statistical analysis | Bacterial infections | Review boards | Mortality | Antimicrobial agents | Patients | Abdomen | Urinary tract diseases | Medicine | Studies | Hospitals | Antibiotics | Pharmacy | Skin | Adults
Journal Article
Clinical infectious diseases, ISSN 1537-6591, 2010, Volume 51, Issue S2, pp. S183 - S197
...) has undergone rapid evolutionary changes and epidemiologic expansion to become a major cause of nosocomial and community-acquired infections worldwide... 
Osteomyelitis | Infectious diseases | Antibiotics | Antimicrobials | Endocarditis | Abscesses | Methicillin resistant staphylococcus aureus | Infections | Staphylococcus aureus | Bacteremia | HEALTH-CARE SETTINGS | INFECTIOUS DISEASES | ANTIMICROBIAL THERAPY | LINEZOLID PNU-100766 | TRANSESOPHAGEAL ECHOCARDIOGRAPHY | CLINDAMYCIN TREATMENT | MICROBIOLOGY | IMMUNOLOGY | INTRANASAL MUPIROCIN | COMPLICATED SKIN | 2 DOUBLE-BLIND | SKIN-STRUCTURE INFECTIONS | NOSOCOMIAL PNEUMONIA | Community-Acquired Infections - diagnosis | Staphylococcal Infections - pathology | Humans | Osteomyelitis - drug therapy | Bacteremia - microbiology | Anti-Bacterial Agents - therapeutic use | Methicillin-Resistant Staphylococcus aureus - pathogenicity | Cross Infection - pathology | Endocarditis, Bacterial - pathology | Community-Acquired Infections - drug therapy | Osteomyelitis - pathology | Endocarditis, Bacterial - microbiology | Staphylococcal Infections - microbiology | Endocarditis, Bacterial - drug therapy | Staphylococcal Infections - drug therapy | Bacteremia - drug therapy | Endocarditis, Bacterial - diagnosis | Bacteremia - diagnosis | Cross Infection - drug therapy | Staphylococcal Infections - diagnosis | Osteomyelitis - diagnosis | Community-Acquired Infections - pathology | Osteomyelitis - microbiology | Cross Infection - microbiology | Cross Infection - diagnosis | Methicillin-Resistant Staphylococcus aureus - isolation & purification | Bacteremia - pathology | Community-Acquired Infections - microbiology
Journal Article
Cochrane library, ISSN 1465-1858, 2017, Volume 2017, Issue 2, p. CD003543
Journal Article